Canilang, Baby Boy .

HRN: 25-29-31  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/17/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/17/2024
06/24/2024
IVT
44mg LD Then 22mg
Q8
GI Obstruction
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: